Type I Interferon Signaling Is Required for Dacryoadenitis in the Nonobese Diabetic Mouse Model of Sjogren Syndrome
Yury Chaly, Jennifer Y Barr, David A Sullivan, Helen E Thomas, Thomas C Brodnicki, Scott M Lieberman
International Journal of Molecular Sciences | MDPI | Published : 2018
Awarded by National Institutes of Health
Awarded by National Health and Medical Research Council of Australia (NHMRC)
Awarded by NHMRC
This research was funded by National Institutes of Health grant numbers EY027731 (S.M.L.) and EY05612 (D.A.S.), National Health and Medical Research Council of Australia (NHMRC, 1037321) and a fellowship from the NHMRC (H.T., 1042735). The data presented herein were obtained at the Flow Cytometry Facility, which is a Carver College of Medicine/Holden Comprehensive Cancer Center core research facility at the University of Iowa. The Facility is funded through user fees and the generous financial support of the Carver College of Medicine, Holden Comprehensive Cancer Center and Iowa City Veteran's Administration Medical Center. St Vincent's Institute laboratories are supported in part by the Victorian Operational Infrastructure Support Program.